Florence Rabian

1.4k total citations
17 papers, 78 citations indexed

About

Florence Rabian is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Florence Rabian has authored 17 papers receiving a total of 78 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Oncology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Florence Rabian's work include Acute Myeloid Leukemia Research (7 papers), CAR-T cell therapy research (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). Florence Rabian is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), CAR-T cell therapy research (6 papers) and Acute Lymphoblastic Leukemia research (6 papers). Florence Rabian collaborates with scholars based in France, Italy and Canada. Florence Rabian's co-authors include Étienne Lengliné, Nicolas Boissel, Delphine Réa, Élie Azoulay, Lara Zafrani, Virginie Lemiale, Sandrine Valade, Bruno Lioure, Claude Preudhomme and Guillaume Dumas and has published in prestigious journals such as Blood, PLoS ONE and American Journal of Hematology.

In The Last Decade

Florence Rabian

15 papers receiving 76 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florence Rabian France 7 44 34 12 12 12 17 78
Audrey M. Sigmund United States 6 46 1.0× 45 1.3× 25 2.1× 36 3.0× 16 1.3× 22 116
Kristin L Koenig United States 4 57 1.3× 24 0.7× 40 3.3× 23 1.9× 18 1.5× 13 98
Atsushi Marumo Japan 6 47 1.1× 12 0.4× 8 0.7× 13 1.1× 17 1.4× 20 71
Habib El‐Khoury United States 6 60 1.4× 28 0.8× 32 2.7× 21 1.8× 14 1.2× 17 102
Vladimir Ivanov Russia 6 38 0.9× 14 0.4× 17 1.4× 12 1.0× 9 0.8× 16 82
Kannadit Prayongratana Thailand 5 42 1.0× 32 0.9× 13 1.1× 15 1.3× 9 0.8× 20 75
Jan‐Michel Heger Germany 6 15 0.3× 56 1.6× 9 0.8× 7 0.6× 7 0.6× 23 82
Moraima Jiménez Spain 4 28 0.6× 41 1.2× 12 1.0× 23 1.9× 5 0.4× 10 93
Alejandro Luna Spain 7 21 0.5× 36 1.1× 8 0.7× 16 1.3× 4 0.3× 15 82
Fatiha Chermat France 5 53 1.2× 15 0.4× 20 1.7× 20 1.7× 10 0.8× 19 73

Countries citing papers authored by Florence Rabian

Since Specialization
Citations

This map shows the geographic impact of Florence Rabian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Rabian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Rabian more than expected).

Fields of papers citing papers by Florence Rabian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Rabian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Rabian. The network helps show where Florence Rabian may publish in the future.

Co-authorship network of co-authors of Florence Rabian

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Rabian. A scholar is included among the top collaborators of Florence Rabian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Rabian. Florence Rabian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lengliné, Étienne, Florence Rabian, Marco Cerrano, et al.. (2024). Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission. Blood Advances. 8(10). 2405–2409. 2 indexed citations
2.
Joseph, Adrien, Catherine Thieblemont, Florence Rabian, et al.. (2024). Acute kidney injury after CAR-T cell therapy: exploring clinical patterns, management, and outcomes. Clinical Kidney Journal. 17(6). 6 indexed citations
3.
Denis, Blandine, Matthieu Resche‐Rigon, Emmanuel Dudoignon, et al.. (2024). Epidemiology, Clinical Manifestations, Treatment, and Outcome of Mucormycosis: A Review of 77 Cases From a Single Center in France. Open Forum Infectious Diseases. 11(8). ofae426–ofae426. 1 indexed citations
4.
Cerrano, Marco, Sylvie Chevret, Emmanuel Raffoux, et al.. (2023). Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis. Annals of Hematology. 102(4). 761–768. 6 indexed citations
5.
Lambert, Jérôme, Roberta Di Blasi, Florence Rabian, et al.. (2023). Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data. HemaSphere. 7(6). e873–e873. 1 indexed citations
6.
7.
Valade, Sandrine, Michaël Darmon, Lara Zafrani, et al.. (2022). The use of ICU resources in CAR-T cell recipients: a hospital-wide study. Annals of Intensive Care. 12(1). 75–75. 10 indexed citations
8.
Fodil, Sofiane, Sylvie Chevret, Sandrine Valade, et al.. (2022). Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications. PLoS ONE. 17(7). e0270744–e0270744. 2 indexed citations
9.
Beauvais, David, Emmanuel Bachy, André Baruchel, et al.. (2021). Éligibilité des patients aux cellules CAR-T : avis d’experts proposé par la SFGM-TC. Bulletin du Cancer. 108(7-8). 725–729. 2 indexed citations
10.
Boissel, Nicolas & Florence Rabian. (2021). Immunotherapies in acute leukemia. Therapies. 77(2). 241–250. 1 indexed citations
11.
Rabian, Florence & Nicolas Boissel. (2020). LAL chez l’adulte : apport et limite de la prise en charge pédiatrique. Bulletin du Cancer. 108(2). 187–197.
12.
Rabian, Florence, Jérôme Lambert, Daniela Barbieri, et al.. (2020). Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Severe Thrombocytopenia: Final Results of a Multicenter Phase II Study. Blood. 136(Supplement 1). 15–16. 2 indexed citations
13.
Rabian, Florence, Hélène Boutroux, Marion Strullu, et al.. (2019). Azacitidine in Pediatric Hematologic Myeloid Malignancies: A Retrospective Study. Blood. 134(Supplement_1). 5130–5130.
14.
Rabian, Florence, Étienne Lengliné, & Delphine Réa. (2019). Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia. Current Hematologic Malignancy Reports. 14(6). 492–500. 10 indexed citations
15.
Cerrano, Marco, Valérie Seegers, Emmanuel Raffoux, et al.. (2019). Predictors and outcomes associated with hydroxyurea sensitivity in acute myeloid leukemia patients with high hyperleukocytosis. Leukemia & lymphoma. 61(3). 737–740. 8 indexed citations
16.
Rabian, Florence, Raphaël Porcher, Flore Sicre de Fontbrune, et al.. (2016). Influence of Previous Inflammatory Bowel Disease on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Matched-Pair Analysis. Biology of Blood and Marrow Transplantation. 22(9). 1721–1724. 7 indexed citations
17.
Pilorge, Sylvain, Sophie Rigaudeau, Florence Rabian, et al.. (2013). Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse. American Journal of Hematology. 89(4). 399–403. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Audrey M. Sigmund Breakdown of academic impact, for papers by Kristin L Koenig Breakdown of academic impact, for papers by Atsushi Marumo Breakdown of academic impact, for papers by Habib El‐Khoury Breakdown of academic impact, for papers by Vladimir Ivanov Breakdown of academic impact, for papers by Kannadit Prayongratana Breakdown of academic impact, for papers by Jan‐Michel Heger Breakdown of academic impact, for papers by Moraima Jiménez Breakdown of academic impact, for papers by Alejandro Luna Breakdown of academic impact, for papers by Fatiha Chermat
Rankless by CCL
2026